XenoPort Rises After Winning U.S. Approval for First Drug

XenoPort Inc. had its biggest gain in Nasdaq trading after U.S. regulators approved its first product following more than a year of delays.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.